氨甲环酸对股骨近端防旋髓内钉治疗高龄患者股骨粗隆间骨折的影响

Effect of tranexamic acid in treatment of elderly patients with femoral intertrochanteric fracture by proximal femoral nail antirotation

  • 摘要:
      目的  探讨氨甲环酸(TXA)对股骨近端防旋髓内钉(PFNA)治疗股骨粗隆间骨折患者的有效性及安全性。
      方法  选取股骨粗隆间骨折住院行PFNA手术的高龄患者70例为研究对象。根据术前是否使用TXA分为对照组和TXA组,每组35例。对照组术前不使用TXA,TXA组术前使用TXA。分析2组患者的临床资料、失血情况,并通过随访比较2组并发症发生情况。
      结果  TXA组患者显性失血量、术中出血量、术后引流量、总失血量及隐性失血量均少于对照组,差异有统计学意义(P < 0.05);TXA组输血率、输血量低于对照组,差异有统计学意义(P < 0.05)。2组患者术后伤口情况、并发症发生率比较,差异无统计学意义(P>0.05)。
      结论  PFNA髓内固定治疗股骨粗隆间骨折患者,于术前静脉注射10 mg/kg TXA,可有效减少高龄患者的隐性失血并降低输血率,且不会增高下肢深静脉血栓和肺栓塞的发生风险,安全有效。

     

    Abstract:
      Objective  To investigate the efficacy and safety of tranexamic acid (TXA) in treatment of elderly patients with femoral intertrochanteric fracture by proximal femoral nail antirotation(PFNA).
      Methods  Seventy elderly patients with intertrochanteric fracture undergoing PFNA surgery were selected as the research subjects. According to whether TXA was used preoperatively, the patients were divided into control group and TXA group, with 35 cases in each group. TXA was not used preoperatively in the control group, while TXA was used preoperatively in the TXA group. The basic clinical data and blood loss of the two groups were analyzed, and the incidence of complications between the two groups was compared through follow-up.
      Results  The dominant blood loss, intraoperative blood loss, postoperative drainage volume, total blood loss and hidden blood loss in the TXA group were significantly less than those in the control group (P < 0.05). The blood transfusion rate and blood transfusion volume in the TXA group were significantly lower and less than those in the control group (P < 0.05). There were no significant differences in postoperative wound condition and incidence of complications between two groups (P>0.05).
      Conclusion  In the treatment of intertrochanteric fracture patients with PFNA intramedullary fixation, preoperative intravenous injection of 10 mg/kg TXA can effectively reduce the hidden blood loss and blood transfusion rate in elderly patients, and will not increase the risk of lower extremity deep vein thrombosis and pulmonary embolism, which is safe and effective.

     

/

返回文章
返回